Artiva Biotherapeutics, Inc.ARTVNASDAQ
Loading
P/E Ratio: Premium ValuationElevated
Percentile Rank83
Studio
Year-over-Year Change

Price-to-earnings ratio

Latest
-1.25
↑ 74% vs avg
Percentile
P83
Within normal range
Streak
2 yr
Consecutive growthElevated
Average
-4.83
Historical baseline
PeriodValueYoY Change
2025-1.25+70.2%
2024-4.20+58.4%
2023-10.09-179.1%
2022-3.61-23.0%
2021-2.94+75.0%
2020-11.73-
20190.00-